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Zika and dengue viruses are members of the Flavivirus genus that share many structural and pathological
characteristics. They cause mild fever, rash and general body pain but can cause severe reactions, as
hemorrhages (dengue virus), congenital syndrome (Zika virus), or even death. After an infection, virus-specific
antibodies are generated by the immune system; however, because of the structural similarity between these
viruses, some antibodies can cross-react with different members of the flavivirus family. After a secondary
infection, the cross-reactive antibodies can lead to the more severe forms of the disease, through a mechanism
named antibody-dependent enhancement of infection (ADE). Recently, some broadly neutralizing antibodies
(antibodies that neutralize both, dengue and Zika, viruses), have been isolated and it has been demonstrated
that they do not induce ADE. These antibodies are directed to a discontinuous quaternary epitope named the
Envelope Dimer Epitope (EDE)1, located in the envelope (E) protein of both viruses. To obtain EDE, it is
necessary to express the complete E protein, which contains other epitopes that induce ADE. This study aims to
generate peptides that emulate the EDE epitope structure (mimotopes) without inducing ADE, and study its
capacity to elicit broadly neutralizing antibodies against dengue and Zika viruses, to obtain a vaccine candidate
for both viruses.
Using the broadly neutralizing antibody EDE1-C8, that does not induce ADE at high titers 2,3, and a phage
display library, we identified three peptides that are recognized by EDE1-C8, but share very low or no identity
with the E protein sequence from dengue and Zika viruses. Thus, they are probably emulating the structure of
the EDE epitope and are EDE mimotopes. The analysis by circular dichroism of the free peptides showed
mainly a random coil folding, characterized by a lack of secondary structure. EDE1-C8 did not recognize these
mimotopes attached chemically to a carrier protein, and free or phage-displayed peptides did not induce
antibodies against native viruses when administered to mice. To improve the stability and folding of the
peptides, we designed and produced adeno-associated virus-like particles (VLPs) that display the mimotopes on
their surface. VLPs were obtained using the baculovirus-insect cell system, with similar size and structure to the
native adeno-associated virus, as determined by cryo-electron microscopy. The modified VLPs were recognized
by the EDE1-C8 antibody in a native Dot-Blot, but not under denaturing conditions, demonstrating that the threedimensional structural conformation of the peptides displayed in the VLPs can mimetize the EDE epitope. The
VLPs displaying mimotope 2, in combination with an adjuvant, elicited antibodies against Zika and dengue
viruses when applied to mice.
Here, we demonstrate that it is possible to emulate a very
conserved epitope in dengue and Zika viruses, with non-related to
protein E peptides. This information is valuable for the design of a
safer dengue and Zika vaccine without ADE. More research is
necessary and undergoing to study the neutralizing and ADE effect
of the antibodies produced in response to the immunization with
these VLPs-displayed mimotopes.
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